SUMMARY 10 children with mesangiocapillary (membranoproliferative) glomerulonephritis with features associated with a poor prognosis (either crescentic nephritis or a decline in renal function occurring after the initial presentation) were treated with a combination of immunosuppression and anticoagulation using corticosteroids, azathioprine, and heparin followed by warfarin and dipyridamole. Children were followed up for between 2 and 5 years, and at the end of this period 2 had died and 2 had entered the dialysis/transplant programme, but 6 were well (5 with glomerular filtration rates greater than 65 ml/min per 1 73m2). We suggest that these results are sufficiently promising to encourage further trials of this form of treatment.
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Mesangiocapillary glomerulonephritis (MCGN) (sometimes called membranoproliferative glomerulonephritis or MPGN) is a disease of childhood and early adult life.' About 40% of patients with MCGN present with a nephrotic syndrome, the remainder with symptomless haematuria or proteinuria, or macroscopic haematuria and an acute nephritic syndrome. A depressed level of serum complement is generally found at some stage of the disease and this is often persistent, but some patients keep a normal serum complement throughout. The diagnosis is made by renal biopsy. The histological features are increased glomerular size, irregular thickening of the glomerular capillary walls, endocapillary proliferation, and an increase in the amount of mesangial matrix and the number of mesangial cells.
Two main histological subtypes are recognised: type I (or subendothelial deposit MCGN) After follow-up from 2 to 5 years (mean 3 4) one child is on dialysis, but the other 4 are well with glomerular filtration rates of 38, 66, 72, and 102 ml/min per 1-73m2. The condition of one child deteriorated after treatment was stopped and he is now on dialysis, and is discussed below; the changes in glomerular filtration rates for the other 4 are shown in Fig. 2 . The child whose glomerular 
The most common complication has been failure to comply with the complicated regimen prescribed, which included hypotensive therapy and diuretics in 6 instances. This may be a reflection of the age group, as most of our patients were adolescents faced with the additional problems of a chronic illness. At least 3 were known to have taken their medications variably and unreliably, which is obviously a particular hazard if anticoagulant dosage is being adjusted according to prothrombin time.
Discussion
The difficulties of assessing treatment efficacy in a fairly rare disease with a variable individual course and an overall mortality of 50% at 10 years have already been mentioned. However, this small group of children were treated with combined anticoagulation and immunosuppression because findings suggested poor prognosis, and renal function has been maintained better than the natural history of the disease would predict. In the large French series2 mortality for MCGN with more than 30% glomeruli showing crescents was 50% at one year and 100 % at 4 years, whereas for our small treated series it was 20 % at one year and 40 % at 2 years. In the French series of 105 cases, only 2 patients in whom a late decline in renal function during follow-up was observed, recovered renal function, whereas all our treated children in this group with later renal failure improved their glomerular filtration rates during treatment. The histological changes are difficult to evaluate without data on changes in untreated patients, but crescents disappeared and cellularity decreased.
The regimen used is complicated, but may be defended from knowledge of the mediation of injury in glomerulonephritis. Antithrombin agents, such as heparin and warfarin, may prevent continued fibrin deposition within and around the glomeruli. Leakage of fibrin into the extraglomerular space appears to be the main cause of crescent formation in experimental glomerulonephritis,8 and although treatment of experimental glomerulonephritis with antithrombin agents has given inconsistent results,5 earlier defibrination with ancrod protects rabbits given anti-GBM antibody nephritis.8 Platelets may be involved in the mediation of injury in nephritis; they certainly facilitate immune complex localisation in the vasculature in animal models.9-10 In MCGN platelet turnover is accelerated 10 and lowered intraplatelet serotonin levels are found.1"
The justification for using immunosuppression as well as anticoagulation is that such a regimen blocks inflammation induced by a variety ofmechanisms, and that even if such treatments alone do not appear to have an effect, the blocking of most or all pathways leading to inflammation at the same time might achieve benefit not obtainable with any agent alone. Combined immunosuppression and anticoagulation was first used in a mixed group of 6 adult patients by Kincaid-Smith et al. 12 The only previous application to children (apart from those included in ourprevious papers)46 wasthatbyRobsonet al.13 who treated 6 children withcrescenticglomerulonephritis (4 of whom had type II MCGN) with antithrombin agents, dipyridamole and azathioprine, for up to 2 years. All had evidence of continuing intravascular coagulation and were selected for that reason. In a brieffollow-up (one year) all 6 responded clinically, with return of renal function to normal, and in 5 biopsied patients histological appearances in the glomeruli improved. It is more difficult to assess the outcome of the 8 children with probable MCGN treated by Herdman et aL.14 with anticoagulants alone, but 4 may have shown benefit.
The reduction in glomerular filtration rate observed in 2 patients on withdrawal is further evidence that the treatment had modified the progress of the disease. It may be that the improvement apparently obtained is only temporary. Only longer follow-up will determine this, but even if all that can be achieved is a postponement of renal failure for a few years during which time physical and emotional growth can continue, this would still be of great value in an illness which is otherwise likely to inflict the rigours of a dialysis-transplant programme on an adolescent already disturbed by chronic illness.
Addendum
During a further year's follow-up, two patients (Cases 4 and 10) have shown sharp deteriorations in function, the former is now on regular haemodialysis, the latter has a glomerular filtration rate of 39 ml/ min. The other 4 patients continue as before, although Case 8 has lost further function. 
